2018-2023 Global Drugs for Malaria Consumption Market Report

August 2018 | 137 pages | ID: 2CCE911FE7FEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Drugs for Malaria market for 2018-2023.

Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.

Anti-malarial Drugs are available only with a physician's prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.


The classification of drugs for malaria includes aryl aminoalcohol compounds, antifolate compounds and artemisinin compounds. The proportion of aryl aminoalcohol compounds drugs for malaria in 2016 is about 16.8%, the proportion of antifolate compounds in 2016 is about 55.4% and the proportion of artemisinin compounds in 2016 is about 27.8%.
Drugs for malaria are application in Preventioning malaria, curing malaria and other areas. The most of drugs for malaria is used in Preventioning malaria; the market share in 2016 is about 56.1%. And 35.1% of drugs for malaria are used in curing malaria.
Market competition is intense. The major manufacturers are Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis and Ajanta Pharma in the United States.
Over the next five years, LPI(LP Information) projects that Drugs for Malaria will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Drugs for Malaria market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Aryl Aminoalcohol Compounds
• Antifolate Compounds
• Artemisinin Compounds

Segmentation by application:

• Prevention
• Treatment
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Cipla
• Guilin Pharmaceutical
• IPCA Laboratories
• GlaxoSmithKline
• Mylan Labs
• Roche
• Novartis
• Sanofi Aventis
• Ajanta Pharma

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Drugs for Malaria consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Drugs for Malaria market by identifying its various subsegments.
• Focuses on the key global Drugs for Malaria manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Drugs for Malaria with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Drugs for Malaria submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Drugs for Malaria Consumption 2013-2023
  2.1.2 Drugs for Malaria Consumption CAGR by Region
2.2 Drugs for Malaria Segment by Type
  2.2.1 Aryl Aminoalcohol Compounds
  2.2.2 Antifolate Compounds
  2.2.3 Artemisinin Compounds
2.3 Drugs for Malaria Consumption by Type
  2.3.1 Global Drugs for Malaria Consumption Market Share by Type (2013-2018)
  2.3.2 Global Drugs for Malaria Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Drugs for Malaria Sale Price by Type (2013-2018)
2.4 Drugs for Malaria Segment by Application
  2.4.1 Prevention
  2.4.2 Treatment
  2.4.3 Other
2.5 Drugs for Malaria Consumption by Application
  2.5.1 Global Drugs for Malaria Consumption Market Share by Application (2013-2018)
  2.5.2 Global Drugs for Malaria Value and Market Share by Application (2013-2018)
  2.5.3 Global Drugs for Malaria Sale Price by Application (2013-2018)

3 GLOBAL DRUGS FOR MALARIA BY PLAYERS

3.1 Global Drugs for Malaria Sales Market Share by Players
  3.1.1 Global Drugs for Malaria Sales by Players (2016-2018)
  3.1.2 Global Drugs for Malaria Sales Market Share by Players (2016-2018)
3.2 Global Drugs for Malaria Revenue Market Share by Players
  3.2.1 Global Drugs for Malaria Revenue by Players (2016-2018)
  3.2.2 Global Drugs for Malaria Revenue Market Share by Players (2016-2018)
3.3 Global Drugs for Malaria Sale Price by Players
3.4 Global Drugs for Malaria Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Drugs for Malaria Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Drugs for Malaria Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 DRUGS FOR MALARIA BY REGIONS

4.1 Drugs for Malaria by Regions
  4.1.1 Global Drugs for Malaria Consumption by Regions
  4.1.2 Global Drugs for Malaria Value by Regions
4.2 Americas Drugs for Malaria Consumption Growth
4.3 APAC Drugs for Malaria Consumption Growth
4.4 Europe Drugs for Malaria Consumption Growth
4.5 Middle East & Africa Drugs for Malaria Consumption Growth

5 AMERICAS

5.1 Americas Drugs for Malaria Consumption by Countries
  5.1.1 Americas Drugs for Malaria Consumption by Countries (2013-2018)
  5.1.2 Americas Drugs for Malaria Value by Countries (2013-2018)
5.2 Americas Drugs for Malaria Consumption by Type
5.3 Americas Drugs for Malaria Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Drugs for Malaria Consumption by Countries
  6.1.1 APAC Drugs for Malaria Consumption by Countries (2013-2018)
  6.1.2 APAC Drugs for Malaria Value by Countries (2013-2018)
6.2 APAC Drugs for Malaria Consumption by Type
6.3 APAC Drugs for Malaria Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Drugs for Malaria by Countries
  7.1.1 Europe Drugs for Malaria Consumption by Countries (2013-2018)
  7.1.2 Europe Drugs for Malaria Value by Countries (2013-2018)
7.2 Europe Drugs for Malaria Consumption by Type
7.3 Europe Drugs for Malaria Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Drugs for Malaria by Countries
  8.1.1 Middle East & Africa Drugs for Malaria Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Drugs for Malaria Value by Countries (2013-2018)
8.2 Middle East & Africa Drugs for Malaria Consumption by Type
8.3 Middle East & Africa Drugs for Malaria Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Drugs for Malaria Distributors
10.3 Drugs for Malaria Customer

11 GLOBAL DRUGS FOR MALARIA MARKET FORECAST

11.1 Global Drugs for Malaria Consumption Forecast (2018-2023)
11.2 Global Drugs for Malaria Forecast by Regions
  11.2.1 Global Drugs for Malaria Forecast by Regions (2018-2023)
  11.2.2 Global Drugs for Malaria Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Drugs for Malaria Forecast by Type
11.8 Global Drugs for Malaria Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Cipla
  12.1.1 Company Details
  12.1.2 Drugs for Malaria Product Offered
  12.1.3 Cipla Drugs for Malaria Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Cipla News
12.2 Guilin Pharmaceutical
  12.2.1 Company Details
  12.2.2 Drugs for Malaria Product Offered
  12.2.3 Guilin Pharmaceutical Drugs for Malaria Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Guilin Pharmaceutical News
12.3 IPCA Laboratories
  12.3.1 Company Details
  12.3.2 Drugs for Malaria Product Offered
  12.3.3 IPCA Laboratories Drugs for Malaria Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 IPCA Laboratories News
12.4 GlaxoSmithKline
  12.4.1 Company Details
  12.4.2 Drugs for Malaria Product Offered
  12.4.3 GlaxoSmithKline Drugs for Malaria Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 GlaxoSmithKline News
12.5 Mylan Labs
  12.5.1 Company Details
  12.5.2 Drugs for Malaria Product Offered
  12.5.3 Mylan Labs Drugs for Malaria Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Mylan Labs News
12.6 Roche
  12.6.1 Company Details
  12.6.2 Drugs for Malaria Product Offered
  12.6.3 Roche Drugs for Malaria Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Roche News
12.7 Novartis
  12.7.1 Company Details
  12.7.2 Drugs for Malaria Product Offered
  12.7.3 Novartis Drugs for Malaria Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Novartis News
12.8 Sanofi Aventis
  12.8.1 Company Details
  12.8.2 Drugs for Malaria Product Offered
  12.8.3 Sanofi Aventis Drugs for Malaria Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Sanofi Aventis News
12.9 Ajanta Pharma
  12.9.1 Company Details
  12.9.2 Drugs for Malaria Product Offered
  12.9.3 Ajanta Pharma Drugs for Malaria Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Ajanta Pharma News

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Drugs for Malaria
Table Product Specifications of Drugs for Malaria
Figure Drugs for Malaria Report Years Considered
Figure Market Research Methodology
Figure Global Drugs for Malaria Consumption Growth Rate 2013-2023 (K Units)
Figure Global Drugs for Malaria Value Growth Rate 2013-2023 ($ Millions)
Table Drugs for Malaria Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Aryl Aminoalcohol Compounds
Table Major Players of Aryl Aminoalcohol Compounds
Figure Product Picture of Antifolate Compounds
Table Major Players of Antifolate Compounds
Figure Product Picture of Artemisinin Compounds
Table Major Players of Artemisinin Compounds
Table Global Consumption Sales by Type (2013-2018)
Table Global Drugs for Malaria Consumption Market Share by Type (2013-2018)
Figure Global Drugs for Malaria Consumption Market Share by Type (2013-2018)
Table Global Drugs for Malaria Revenue by Type (2013-2018) ($ million)
Table Global Drugs for Malaria Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Drugs for Malaria Value Market Share by Type (2013-2018)
Table Global Drugs for Malaria Sale Price by Type (2013-2018)
Figure Drugs for Malaria Consumed in Prevention
Figure Global Drugs for Malaria Market: Prevention (2013-2018) (K Units)
Figure Global Drugs for Malaria Market: Prevention (2013-2018) ($ Millions)
Figure Global Prevention YoY Growth ($ Millions)
Figure Drugs for Malaria Consumed in Treatment
Figure Global Drugs for Malaria Market: Treatment (2013-2018) (K Units)
Figure Global Drugs for Malaria Market: Treatment (2013-2018) ($ Millions)
Figure Global Treatment YoY Growth ($ Millions)
Figure Drugs for Malaria Consumed in Other
Figure Global Drugs for Malaria Market: Other (2013-2018) (K Units)
Figure Global Drugs for Malaria Market: Other (2013-2018) ($ Millions)
Figure Global Other YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Drugs for Malaria Consumption Market Share by Application (2013-2018)
Figure Global Drugs for Malaria Consumption Market Share by Application (2013-2018)
Table Global Drugs for Malaria Value by Application (2013-2018)
Table Global Drugs for Malaria Value Market Share by Application (2013-2018)
Figure Global Drugs for Malaria Value Market Share by Application (2013-2018)
Table Global Drugs for Malaria Sale Price by Application (2013-2018)
Table Global Drugs for Malaria Sales by Players (2016-2018) (K Units)
Table Global Drugs for Malaria Sales Market Share by Players (2016-2018)
Figure Global Drugs for Malaria Sales Market Share by Players in 2016
Figure Global Drugs for Malaria Sales Market Share by Players in 2017
Table Global Drugs for Malaria Revenue by Players (2016-2018) ($ Millions)
Table Global Drugs for Malaria Revenue Market Share by Players (2016-2018)
Figure Global Drugs for Malaria Revenue Market Share by Players in 2016
Figure Global Drugs for Malaria Revenue Market Share by Players in 2017
Table Global Drugs for Malaria Sale Price by Players (2016-2018)
Figure Global Drugs for Malaria Sale Price by Players in 2017
Table Global Drugs for Malaria Manufacturing Base Distribution and Sales Area by Players
Table Players Drugs for Malaria Products Offered
Table Drugs for Malaria Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Drugs for Malaria Consumption by Regions 2013-2018 (K Units)
Table Global Drugs for Malaria Consumption Market Share by Regions 2013-2018
Figure Global Drugs for Malaria Consumption Market Share by Regions 2013-2018
Table Global Drugs for Malaria Value by Regions 2013-2018 ($ Millions)
Table Global Drugs for Malaria Value Market Share by Regions 2013-2018
Figure Global Drugs for Malaria Value Market Share by Regions 2013-2018
Figure Americas Drugs for Malaria Consumption 2013-2018 (K Units)
Figure Americas Drugs for Malaria Value 2013-2018 ($ Millions)
Figure APAC Drugs for Malaria Consumption 2013-2018 (K Units)
Figure APAC Drugs for Malaria Value 2013-2018 ($ Millions)
Figure Europe Drugs for Malaria Consumption 2013-2018 (K Units)
Figure Europe Drugs for Malaria Value 2013-2018 ($ Millions)
Figure Middle East & Africa Drugs for Malaria Consumption 2013-2018 (K Units)
Figure Middle East & Africa Drugs for Malaria Value 2013-2018 ($ Millions)
Table Americas Drugs for Malaria Consumption by Countries (2013-2018) (K Units)
Table Americas Drugs for Malaria Consumption Market Share by Countries (2013-2018)
Figure Americas Drugs for Malaria Consumption Market Share by Countries in 2017
Table Americas Drugs for Malaria Value by Countries (2013-2018) ($ Millions)
Table Americas Drugs for Malaria Value Market Share by Countries (2013-2018)
Figure Americas Drugs for Malaria Value Market Share by Countries in 2017
Table Americas Drugs for Malaria Consumption by Type (2013-2018) (K Units)
Table Americas Drugs for Malaria Consumption Market Share by Type (2013-2018)
Figure Americas Drugs for Malaria Consumption Market Share by Type in 2017
Table Americas Drugs for Malaria Consumption by Application (2013-2018) (K Units)
Table Americas Drugs for Malaria Consumption Market Share by Application (2013-2018)
Figure Americas Drugs for Malaria Consumption Market Share by Application in 2017
Figure United States Drugs for Malaria Consumption Growth 2013-2018 (K Units)
Figure United States Drugs for Malaria Value Growth 2013-2018 ($ Millions)
Figure Canada Drugs for Malaria Consumption Growth 2013-2018 (K Units)
Figure Canada Drugs for Malaria Value Growth 2013-2018 ($ Millions)
Figure Mexico Drugs for Malaria Consumption Growth 2013-2018 (K Units)
Figure Mexico Drugs for Malaria Value Growth 2013-2018 ($ Millions)
Table APAC Drugs for Malaria Consumption by Countries (2013-2018) (K Units)
Table APAC Drugs for Malaria Consumption Market Share by Countries (2013-2018)
Figure APAC Drugs for Malaria Consumption Market Share by Countries in 2017
Table APAC Drugs for Malaria Value by Countries (2013-2018) ($ Millions)
Table APAC Drugs for Malaria Value Market Share by Countries (2013-2018)
Figure APAC Drugs for Malaria Value Market Share by Countries in 2017
Table APAC Drugs for Malaria Consumption by Type (2013-2018) (K Units)
Table APAC Drugs for Malaria Consumption Market Share by Type (2013-2018)
Figure APAC Drugs for Malaria Consumption Market Share by Type in 2017
Table APAC Drugs for Malaria Consumption by Application (2013-2018) (K Units)
Table APAC Drugs for Malaria Consumption Market Share by Application (2013-2018)
Figure APAC Drugs for Malaria Consumption Market Share by Application in 2017
Figure China Drugs for Malaria Consumption Growth 2013-2018 (K Units)
Figure China Drugs for Malaria Value Growth 2013-2018 ($ Millions)
Figure Japan Drugs for Malaria Consumption Growth 2013-2018 (K Units)
Figure Japan Drugs for Malaria Value Growth 2013-2018 ($ Millions)
Figure Korea Drugs for Malaria Consumption Growth 2013-2018 (K Units)
Figure Korea Drugs for Malaria Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Drugs for Malaria Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Drugs for Malaria Value Growth 2013-2018 ($ Millions)
Figure India Drugs for Malaria Consumption Growth 2013-2018 (K Units)
Figure India Drugs for Malaria Value Growth 2013-2018 ($ Millions)
Figure Australia Drugs for Malaria Consumption Growth 2013-2018 (K Units)
Figure Australia Drugs for Malaria Value Growth 2013-2018 ($ Millions)
Table Europe Drugs for Malaria Consumption by Countries (2013-2018) (K Units)
Table Europe Drugs for Malaria Consumption Market Share by Countries (2013-2018)
Figure Europe Drugs for Malaria Consumption Market Share by Countries in 2017
Table Europe Drugs for Malaria Value by Countries (2013-2018) ($ Millions)
Table Europe Drugs for Malaria Value Market Share by Countries (2013-2018)
Figure Europe Drugs for Malaria Value Market Share by Countries in 2017
Table Europe Drugs for Malaria Consumption by Type (2013-2018) (K Units)
Table Europe Drugs for Malaria Consumption Market Share by Type (2013-2018)
Figure Europe Drugs for Malaria Consumption Market Share by Type in 2017
Table Europe Drugs for Malaria Consumption by Application (2013-2018) (K Units)
Table Europe Drugs for Malaria Consumption Market Share by Application (2013-2018)
Figure Europe Drugs for Malaria Consumption Market Share by Application in 2017
Figure Germany Drugs for Malaria Consumption Growth 2013-2018 (K Units)
Figure Germany Drugs for Malaria Value Growth 2013-2018 ($ Millions)
Figure France Drugs for Malaria Consumption Growth 2013-2018 (K Units)
Figure France Drugs for Malaria Value Growth 2013-2018 ($ Millions)
Figure UK Drugs for Malaria Consumption Growth 2013-2018 (K Units)
Figure UK Drugs for Malaria Value Growth 2013-2018 ($ Millions)
Figure Italy Drugs for Malaria Consumption Growth 2013-2018 (K Units)
Figure Italy Drugs for Malaria Value Growth 2013-2018 ($ Millions)
Figure Russia Drugs for Malaria Consumption Growth 2013-2018 (K Units)
Figure Russia Drugs for Malaria Value Growth 2013-2018 ($ Millions)
Figure Spain Drugs for Malaria Consumption Growth 2013-2018 (K Units)
Figure Spain Drugs for Malaria Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Drugs for Malaria Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Drugs for Malaria Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Drugs for Malaria Consumption Market Share by Countries in 2017
Table Middle East & Africa Drugs for Malaria Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Drugs for Malaria Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Drugs for Malaria Value Market Share by Countries in 2017
Table Middle East & Africa Drugs for Malaria Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Drugs for Malaria Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Drugs for Malaria Consumption Market Share by Type in 2017
Table Middle East & Africa Drugs for Malaria Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Drugs for Malaria Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Drugs for Malaria Consumption Market Share by Application in 2017
Figure Egypt Drugs for Malaria Consumption Growth 2013-2018 (K Units)
Figure Egypt Drugs for Malaria Value Growth 2013-2018 ($ Millions)
Figure South Africa Drugs for Malaria Consumption Growth 2013-2018 (K Units)
Figure South Africa Drugs for Malaria Value Growth 2013-2018 ($ Millions)
Figure Israel Drugs for Malaria Consumption Growth 2013-2018 (K Units)
Figure Israel Drugs for Malaria Value Growth 2013-2018 ($ Millions)
Figure Turkey Drugs for Malaria Consumption Growth 2013-2018 (K Units)
Figure Turkey Drugs for Malaria Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Drugs for Malaria Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Drugs for Malaria Value Growth 2013-2018 ($ Millions)
Table Drugs for Malaria Distributors List
Table Drugs for Malaria Customer List
Figure Global Drugs for Malaria Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Drugs for Malaria Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Drugs for Malaria Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Drugs for Malaria Consumption Market Forecast by Regions
Table Global Drugs for Malaria Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Drugs for Malaria Value Market Share Forecast by Regions
Figure Americas Drugs for Malaria Consumption 2018-2023 (K Units)
Figure Americas Drugs for Malaria Value 2018-2023 ($ Millions)
Figure APAC Drugs for Malaria Consumption 2018-2023 (K Units)
Figure APAC Drugs for Malaria Value 2018-2023 ($ Millions)
Figure Europe Drugs for Malaria Consumption 2018-2023 (K Units)
Figure Europe Drugs for Malaria Value 2018-2023 ($ Millions)
Figure Middle East & Africa Drugs for Malaria Consumption 2018-2023 (K Units)
Figure Middle East & Africa Drugs for Malaria Value 2018-2023 ($ Millions)
Figure United States Drugs for Malaria Consumption 2018-2023 (K Units)
Figure United States Drugs for Malaria Value 2018-2023 ($ Millions)
Figure Canada Drugs for Malaria Consumption 2018-2023 (K Units)
Figure Canada Drugs for Malaria Value 2018-2023 ($ Millions)
Figure Mexico Drugs for Malaria Consumption 2018-2023 (K Units)
Figure Mexico Drugs for Malaria Value 2018-2023 ($ Millions)
Figure Brazil Drugs for Malaria Consumption 2018-2023 (K Units)
Figure Brazil Drugs for Malaria Value 2018-2023 ($ Millions)
Figure China Drugs for Malaria Consumption 2018-2023 (K Units)
Figure China Drugs for Malaria Value 2018-2023 ($ Millions)
Figure Japan Drugs for Malaria Consumption 2018-2023 (K Units)
Figure Japan Drugs for Malaria Value 2018-2023 ($ Millions)
Figure Korea Drugs for Malaria Consumption 2018-2023 (K Units)
Figure Korea Drugs for Malaria Value 2018-2023 ($ Millions)
Figure Southeast Asia Drugs for Malaria Consumption 2018-2023 (K Units)
Figure Southeast Asia Drugs for Malaria Value 2018-2023 ($ Millions)
Figure India Drugs for Malaria Consumption 2018-2023 (K Units)
Figure India Drugs for Malaria Value 2018-2023 ($ Millions)
Figure Australia Drugs for Malaria Consumption 2018-2023 (K Units)
Figure Australia Drugs for Malaria Value 2018-2023 ($ Millions)
Figure Germany Drugs for Malaria Consumption 2018-2023 (K Units)
Figure Germany Drugs for Malaria Value 2018-2023 ($ Millions)
Figure France Drugs for Malaria Consumption 2018-2023 (K Units)
Figure France Drugs for Malaria Value 2018-2023 ($ Millions)
Figure UK Drugs for Malaria Consumption 2018-2023 (K Units)
Figure UK Drugs for Malaria Value 2018-2023 ($ Millions)
Figure Italy Drugs for Malaria Consumption 2018-2023 (K Units)
Figure Italy Drugs for Malaria Value 2018-2023 ($ Millions)
Figure Russia Drugs for Malaria Consumption 2018-2023 (K Units)
Figure Russia Drugs for Malaria Value 2018-2023 ($ Millions)
Figure Spain Drugs for Malaria Consumption 2018-2023 (K Units)
Figure Spain Drugs for Malaria Value 2018-2023 ($ Millions)
Figure Egypt Drugs for Malaria Consumption 2018-2023 (K Units)
Figure Egypt Drugs for Malaria Value 2018-2023 ($ Millions)
Figure South Africa Drugs for Malaria Consumption 2018-2023 (K Units)
Figure South Africa Drugs for Malaria Value 2018-2023 ($ Millions)
Figure Israel Drugs for Malaria Consumption 2018-2023 (K Units)
Figure Israel Drugs for Malaria Value 2018-2023 ($ Millions)
Figure Turkey Drugs for Malaria Consumption 2018-2023 (K Units)
Figure Turkey Drugs for Malaria Value 2018-2023 ($ Millions)
Figure GCC Countries Drugs for Malaria Consumption 2018-2023 (K Units)
Figure GCC Countries Drugs for Malaria Value 2018-2023 ($ Millions)
Table Global Drugs for Malaria Consumption Forecast by Type (2018-2023) (K Units)
Table Global Drugs for Malaria Consumption Market Share Forecast by Type (2018-2023)
Table Global Drugs for Malaria Value Forecast by Type (2018-2023) ($ Millions)
Table Global Drugs for Malaria Value Market Share Forecast by Type (2018-2023)
Table Global Drugs for Malaria Consumption Forecast by Application (2018-2023) (K Units)
Table Global Drugs for Malaria Consumption Market Share Forecast by Application (2018-2023)
Table Global Drugs for Malaria Value Forecast by Application (2018-2023) ($ Millions)
Table Global Drugs for Malaria Value Market Share Forecast by Application (2018-2023)
Table Cipla Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cipla Drugs for Malaria Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Cipla Drugs for Malaria Market Share (2016-2018)
Table Guilin Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Guilin Pharmaceutical Drugs for Malaria Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Guilin Pharmaceutical Drugs for Malaria Market Share (2016-2018)
Table IPCA Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table IPCA Laboratories Drugs for Malaria Sales, Revenue, Price and Gross Margin (2016-2018)
Figure IPCA Laboratories Drugs for Malaria Market Share (2016-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Drugs for Malaria Sales, Revenue, Price and Gross Margin (2016-2018)
Figure GlaxoSmithKline Drugs for Malaria Market Share (2016-2018)
Table Mylan Labs Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mylan Labs Drugs for Malaria Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Mylan Labs Drugs for Malaria Market Share (2016-2018)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Drugs for Malaria Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Roche Drugs for Malaria Market Share (2016-2018)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Drugs for Malaria Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Novartis Drugs for Malaria Market Share (2016-2018)
Table Sanofi Aventis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Aventis Drugs for Malaria Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sanofi Aventis Drugs for Malaria Market Share (2016-2018)
Table Ajanta Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ajanta Pharma Drugs for Malaria Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Ajanta Pharma Drugs for Malaria Market Share (2016-2018)